Title: 2015 ACVIM Forum Research Abstract Program Document date: 2015_5_27
ID: 3pnuj5ru_10
Snippet: In conclusion, this is the first study to demonstrate that plasma BNP-POC differentiates cardiac from non-cardiac causes of pleural effusion with sensitivity (95.2%) and specificity (87.5%) similar to those of BNP-quant. However, the pleural fluid BNP-POC test is of limited clinical utility, since a positive result is a non-diagnostic finding due to low specificity, although a negative result helps rule out cardiac causes of pleural effusion. The.....
Document: In conclusion, this is the first study to demonstrate that plasma BNP-POC differentiates cardiac from non-cardiac causes of pleural effusion with sensitivity (95.2%) and specificity (87.5%) similar to those of BNP-quant. However, the pleural fluid BNP-POC test is of limited clinical utility, since a positive result is a non-diagnostic finding due to low specificity, although a negative result helps rule out cardiac causes of pleural effusion. There is evidence in human patients with congestive heart failure (CHF) that therapy designed to achieve a certain reduction in N-terminal pro-B-type natriuretic peptide (NT-proBNP) improves outcomes. In one previous study, dogs with CHF that experienced lower NT-proBNP following conventional therapy survived longer than those with persistently high measurements. It is unknown whether it is possible to purposely change plasma NT-proBNP concentration by adjusting medical therapy in dogs. The aim of the present study was to determine whether a prespecified therapeutic algorithm would result in reductions in plasma NT-proBNP concentration in dogs with chronic CHF secondary to MMVD.
Search related documents:
Co phrase search for related documents- bnp quant and cardiac cause: 1
- cardiac cause and CHF congestive heart failure: 1
- cardiac cause and congestive heart failure: 1, 2, 3, 4
- cardiac cause and heart failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- certain reduction and heart failure: 1
- CHF congestive heart failure and clinical utility: 1
- CHF congestive heart failure and congestive heart failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- CHF congestive heart failure and heart failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- CHF dog and congestive heart failure: 1
- CHF dog and heart failure: 1
- clinical utility and congestive heart failure: 1, 2, 3
- clinical utility and heart failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- clinical utility and limited clinical utility: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- clinical utility and low specificity: 1, 2, 3, 4, 5
- congestive heart failure and heart failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- congestive heart failure and low specificity: 1
- conventional therapy and heart failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- heart failure and human patient: 1
- heart failure and low specificity: 1
Co phrase search for related documents, hyperlinks ordered by date